Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2807 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

UCB wins FDA approval for seizure drug

Keppra XR is expected to be available in US pharmacies at the end of September 2008. The goal of therapy with antiepileptic drugs is freedom from seizures and

Johnson & Johnson’s vice chairman to retire

Ms Poon began her career with Johnson & Johnson in November, 2000, as company group chairman of pharmaceuticals. Ms Poon was later appointed worldwide chairman, Medicines & Nutritionals,

Power3 Medical names new interim CEO

Steven Rash has resigned as CEO and chairman of Power3. Mr Rash’s employment ceased on September 3, 2008, as did his service as a director of the company.